Venous thromboembolism prophylaxis after total knee or hip replacement: Treatment pattern and outcomes

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 9, 2011, Pages 972-978

  Penning van Beest, Fernie J A ^a   Overbeek, Jetty A ^a   Meijer, Willemijn M ^a   Woodruff, Kimberly ^b   Jackson, Joseph ^c   van der Vis, Harm ^d   van der Linden, Paul ^e   Herings, Ron M C ^a,f  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b PFIZER INC   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d AVE Orthopedic Clinics   (Netherlands)

^e TERGOOI HOSPITAL   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Major bleeding; Thromboprophylaxis; Total hip replacement; Total knee replacement; Venous thromboembolism; Wound infection

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 80052371577     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2187     Document Type: Article

References (16)

1. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: A meta-analysis of the randomised trials. Lancet 2001;358:9-15.
2. Hull RD, Pineo GF, Stein PD et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: A systematic review. Ann Intern Med 2001;135:858-69.
3. Geerts WH, Bergqvist D, Pineo GF et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381S-453S.
4. Buller HR, van der Meer J, Oudkerk M. [CBO guideline: Deep venous thrombosis and pulmonary embolism; revision of the earlier guidelines. Dutch Organization for Quality Assurance in Hospitals]. Ned Tijdschr Geneeskd 2000;144:1531-7.
5. Bozic KJ, Vail TP, Pekow PS et al. Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty 2010;25:1053-60.
6. Hull RD, Yusen RD, Bergqvist D. State-of-the-art review: Assessing the safety profiles of new anticoagulants for major orthopedic surgery thromboprophylaxis. Clin Appl Thromb Hemost 2009;15:377-88.
7. Patel VP, Walsh M, Sehgal B et al. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 2007;89:33-8.
8. Bjornara BT, Gudmundsen TE, Dahl OE. Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg Br 2006;88:386-91.
9. Clayton RA, Gaston P, Watts AC, Howie CR. Thromboembolic disease after total knee replacement: experience of 5100 cases. Knee 2009;16:18-21.
10. Kwong LM, Happe LE, Horblyuk R, Farrelly E. Decreased venous thromboembolism with injectable vs oral anticoagulation after discharge for major orthopedic surgery. J Arthroplasty 2008;23:25-30.
11. Liu SS, Della Valle AG, Besculides MC et al. Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States. Int Orthop 2009;33:643-51.
12. Warwick D, Friedman RJ, Agnelli G et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: Findings from the Global Orthopaedic Registry. J Bone Joint Surg Br 2007;89:799-807.
13. Herings RMC. PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in the Netherlands. Thesis. Department of Pharmacoepidemiology and Pharmacotherapy. Utrecht: Utrecht University; 1993:207.
14. Cohen AT, Tapson VF, Bergmann JF et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study. Lancet 2008;371:387-94.
15. Deitelzweig SB, McKean SC, Amin AN et al. Prevention of venous thromboembolism in the orthopedic surgery patient. Cleve Clin J Med 2008;75 Suppl 3:S27-36.
16. Eriksson BI, Quinlan DJ. Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery. Drugs 2006;66:1411-29.